Rapid high yield production of different glycoforms of Ebola virus monoclonal antibody.

por Alexandra Castilho, Natasha Bohorova, Josephine Grass, Ognian Bohorov, Larry Zeitlin, Kevin Whaley, Friedrich Altmann, Herta Steinkellner
Publicado 2011

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment

por Robert W. Cross, Zachary A. Bornholdt, Abhishek N. Prasad, Joan B. Geisbert, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer, Kevin Melody, Karla A. Fenton, Heinz Feldmann, Armand Sprecher, Larry Zeitlin, Thomas W. Geisbert
Publicado 2020

Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV

por Amanda L. Phelps, Lyn M. O’Brien, David O. Ulaeto, Frederick W. Holtsberg, Grant C. Liao, Robin Douglas, M. Javad Aman, Pamela J. Glass, Crystal L. Moyer, Jane Ennis, Larry Zeitlin, Les P. Nagata, Wei-Gang Hu
Publicado 2021

Combination therapy protects macaques against advanced Marburg virus disease

por Robert W. Cross, Zachary A. Bornholdt, Abhishek N. Prasad, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer, Dafna M. Abelson, Do H. Kim, William S. Shestowsky, Lioudmila A. Campbell, Elaine Bunyan, Joan B. Geisbert, Karla A. Fenton, Larry Zeitlin, Danielle P. Porter, Thomas W. Geisbert
Publicado 2021